ABLE Financial Group’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-5,818
Closed -$507K 215
2025
Q2
$507K Buy
5,818
+854
+17% +$72.4K 0.12% 122
2025
Q1
$446K Sell
4,964
-1,036
-17% -$92.7K 0.13% 112
2024
Q4
$479K Sell
6,000
-586
-9% -$50.7K 0.14% 106
2024
Q3
$593K Buy
6,586
+131
+2% +$11K 0.18% 85
2024
Q2
$508K Buy
6,455
+1,113
+21% +$91.2K 0.18% 92
2024
Q1
$466K Sell
5,342
-1,366
-20% -$117K 0.18% 93
2023
Q4
$553K Sell
6,708
-6,091
-48% -$464K 0.24% 75
2023
Q3
$1M Sell
12,799
-5,824
-31% -$488K 0.5% 37
2023
Q2
$1.64M Buy
18,623
+1,547
+9% +$133K 0.85% 27
2023
Q1
$1.38M Buy
+17,076
New +$1.39M 0.9% 28

Other funds holding MDT

ABLE Financial Group's MDT Position: Q3 2025 in Review

ABLE Financial Group sold out of Medtronic (MDT) in Q3 2025, closing a stake of 5,818 shares — an estimated $507K sold.

ABLE Financial Group first reported a position in MDT in Q1 2023 and held it in 10 quarters. The position peaked at $1.64M in Q2 2023. 2,169 funds tracked by Wall St. Rank hold MDT as of Q3 2025.

  • ABLE Financial Group reported no remaining Medtronic position as of Q3 2025 after selling out during the quarter.
  • ABLE Financial Group sold 5,818 Medtronic shares in Q3 2025, an estimated $507K.
  • ABLE Financial Group first reported a position in Medtronic in Q1 2023 and held it in 10 quarters.
  • ABLE Financial Group's Medtronic position peaked at $1.64M in Q2 2023.
  • 2,169 funds tracked by Wall St. Rank held Medtronic as of Q3 2025.

Based on ABLE Financial Group's 13F filing for Q3 2025, filed 10 Oct 2025.